MedPage Today on MSN
RFK Jr. Says FDA Will Lift Ban on Peptides
Physicians remain wary of the wellness trend ...
In hormone receptor (HR)–positive, HER2-negative advanced breast cancer, starting CDK4/6 inhibitors (CDK4/6i) in the first ...
USD 11.58 billion; 2031 Projected Market Size: USD 16.39 billion; CAGR (2026–2031): 7.2%; Chemiluminescence Immun ...
According to MarketsandMarkets, the Chemiluminescence Immunoassay Market is projected to grow from about USD 11.58 billion in 2026 to USD 16.39 ...
TriSalus Life Sciences, Inc. (NASDAQ:TLSI) Q4 2025 Earnings Call Transcript March 5, 2026 TriSalus Life Sciences, Inc. beats earnings expectations. Reported EPS is $-0.12, expectations were $-0.13.
February 2026 proved to be a pivotal month for the oncology landscape, as the FDA green-lit several therapies targeting some ...
Resolution of Chronic Fatigue in a Patient With Post-COVID EBV Reactivation and Mold-Related Illness
Dr. Kasey Holland Hamski, ND A case illustrating the interplay between EBV reactivation, environmental mold exposure, and ...
Melanie Stein, ND Clinical improvement in treatment-refractory MCAS with normal conventional biomarkers and profound oral ...
Few topics provoke as much concern as the perception that puberty is beginning earlier than ever. While synthetic ...
A report from the world's leading scientific and medical experts on hormone-related health conditions raises new concerns about the profound threats to human health from endocrine disrupting chemicals ...
Canfor (TSE:CFP) management used its fourth-quarter 2025 results call to outline ongoing pressure from weak lumber and pulp ...
In a joint guidance document issued by the European Society for Paediatric Endocrinology and European Society of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results